Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of 139.93 million as of July 3, 2025. Its market cap has decreased by -25.20% in one year.

Market Cap

139.93M

Enterprise Value

178.06M

Revenue

48.21M

Ranking

n/a

PE Ratio

9.70

Stock Price

7.18

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 139.93M, a decrease of -54.72%. That is a compound annual growth rate of -4.18%.

Market Cap History

Date	Market Cap	% Change
Jul 3, 2025	139.93M	-19.65%
Dec 30, 2024	174.16M	97.16%
Dec 29, 2023	88.33M	219.35%
Dec 30, 2022	27.66M	-4.32%
Dec 30, 2021	28.91M	-24.65%
Dec 30, 2020	38.37M	-66.14%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Roche Holding AG	208.60B
Novartis AG	192.85B
Lonza Group AG	39.47B
Alcon	35.15B
Galderma Group AG	27.94B
Sandoz Group AG	18.36B
Straumann Holding AG	17.12B
Sonova Holding AG	14.12B

Market Cap Rankings